San Diego, CA (June, 1 - 2, 2016)
The discovery of penicillin in 1928 was a major success and antibiotics have been used to treat a large number of patients with infectious disease. Over the almost 100 years since Fleming's discovery of penicillin, the bugs have developed resistance to antibiotics and continue to adapt at an disturbing rate to new and emerging therapies. The increase and spread of antibiotic-resistance and the reduced investment by the pharmaceutical industry have given us an unsettling glimpse of a post-antibiotic era. Ultimately, it is the goal of the scientific community, and certainly that of the attendees, to forestall that event and to prevent the serious consequences that would come inevitably from it.
The 2nd Bugs & Drugs: Antibacterial Drug Discovery conference is designed to bring leaders from academic, pharmaceutical and biotech communities, scientists and clinicians together for 2 days to discuss the development and discovery of new antibiotics, new diagnostics, new targets and non-traditional approaches to tackling multi-drug resistance.
More: https://www.gtcbio.com/conferences/bugs-drugs-antibacterial-discovery-
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Environmetal biotechnology - Information about environmetal biotechnology at Wikipedia
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
In a breakthrough, diabetics damaged cells regenerated to produce insulin
New fuel cell harvests energy from microbes in soil to power sensors, communications